Beckman Coulter's Q4 Revenues Rise 22 Percent Aided by Olympus Acquisition | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter reported after the close of the market Thursday that its fourth-quarter revenues increased 22 percent, with the addition of Olympus Diagnostics' revenues contributing 14 percent of that growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.